Hemangioendothelial sarcoma of the liver associated with long-term estrogen therapy in a man
- 1 November 1980
- journal article
- case report
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 25 (11) , 879-883
- https://doi.org/10.1007/bf01338532
Abstract
An elderly male patient developed a hemangioendothelial sarcoma of the liver after 9 years of stilbestrol therapy. The latter had been commenced as treatment for presumed carcinoma of the prostate. However, the latter diagnosis was never established, even at a subsequent autopsy, and presumably this was the reason he survived and had such a long course of treatment. It is suggested that there was a causal relationship between the estrogen therapy and the development of the sarcoma. The suggestion is supported by the fact that one similar case has been reported, and by recent evidence that hemangioendothelial sarcoma may be associated with the long-term use of androgenic-anabolic steroids.Keywords
This publication has 19 references indexed in Scilit:
- Hepatic reactions to drugs.Gut, 1979
- Hepatocellular carcinoma possibly induced by oral contraceptivesDigestive Diseases and Sciences, 1978
- LIVER TUMOURS AND ORAL CONTRACEPTIVESThe Lancet, 1976
- Histological evidence of carcinoma in a hepatic tumour associated with oral contraceptives.BMJ, 1975
- Hepatic adenomas and oral contraceptives.Gut, 1975
- ANDROGEN-INDUCED HEPATOMAThe Lancet, 1975
- ANGIOSARCOMA OF THE LIVER IN A VINYL-CHLORIDE WORKERThe Lancet, 1974
- POSSIBLE ASSOCIATION BETWEEN BENIGN HEPATOMAS AND ORAL CONTRACEPTIVESThe Lancet, 1973
- ASSOCIATION OF ANDROGENIC-ANABOLIC STEROID THERAPY WITH DEVELOPMENT OF HEPATOCELLULAR CARCINOMAPublished by Elsevier ,1972
- Effect of oestrogen on liver function of prostatic cancer patientsBMJ, 1969